v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Operating expenses:    
Research and development $ 27,610 $ 22,119
Selling, general and administrative 16,169 15,684
Total operating expenses 43,779 37,803
Loss from operations (43,779) (37,803)
Other income, net:    
Interest income 2,570 2,231
Other expense, net (75) (335)
Total other income, net 2,495 1,896
Net loss $ (41,284) $ (35,907)
Net loss per share - basic $ (0.37) $ (0.42)
Net loss per share - diluted $ (0.37) $ (0.42)
Weighted-average shares used in computing net loss per share - basic 110,563,360 85,697,108
Weighted-average shares used in computing net loss per share - diluted 110,563,360 85,697,108